The Russian Direct Investment Fund has reached agreements with the leading pharmaceutical companies aimed at the production of more than 850 million doses per year. DGCI Approves Use of Russian Vaccine Sputnik V in India, 60th Country to Do So
The Russian Direct Investment Fund has reached agreements with the leading pharmaceutical companies aimed at the production of more than 850 million doses per year. DGCI Approves Use of Russian Vaccine Sputnik V in India, 60th Country to Do So
No comments:
Post a Comment